Goodwin Releases Update to Its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
December 07, 2024
December 07, 2024
BOSTON, Massachusetts, Dec. 7 -- Goodwin, a law firm, issued the following news release on Dec. 6, 2024:
Global law firm Goodwin today announced the release of the 2024-2025 annual update to its definitive biosimilars treatise Guide to Biosimilars Litigation and Regulation in the U.S. The Guide, first launched in 2019, is the industry's first and leading compendium of the laws and regulations governing biosimilars in the U.S., and is authored by a multidisciplinary team of experts d . . .
Global law firm Goodwin today announced the release of the 2024-2025 annual update to its definitive biosimilars treatise Guide to Biosimilars Litigation and Regulation in the U.S. The Guide, first launched in 2019, is the industry's first and leading compendium of the laws and regulations governing biosimilars in the U.S., and is authored by a multidisciplinary team of experts d . . .